YEM Search

Plant Summary

Plant Information

TCMBANKHE002700

TCMBank_ID:	TCMBANKHE002700
ID:	TCMBANKHE002700
植物拉丁名:	Cornu Saigae Tataricae
功能与主治:	Treatment of high fever with convulsion and impairment of consciousness, eclompsia, epilepsy, mamia, headache and dizziness, redness of the eye with corneal opacity, epidemic fibrile diseases with eruption, carbuncle, abscess and sores./1. Intraperitoneal injection of its alcoholic extract (0.05mg/g) exerts sedative effect in mice.2. Its alcoholic extract and hydrolsate lower vaccine-induced fever in rabbits.3. Analgesic, anti-convulsive and hypotensive.
药用植物名:	羚羊角
药用部位:	Saiga tatarica Linnaeus
药味:	Cold; Salty
经络:	Liver; Heart
临床特征:	1. Intraperitoneal injection of its alcoholic extract (0.05mg/g) exerts sedative effect in mice.2. Its alcoholic extract and hydrolsate lower vaccine-induced fever in rabbits.3. Analgesic, anti-convulsive and hypotensive.
治疗类型:	平肝息风
TCM_ID_id:	1911
TCMSP_id:	459

植物对应的化合物

化合物ID	化合物名	别名	分子式	分子质量	Smiles

TCMBANKIN000310	Lai tryptophan
TCMBANKIN006351	keratin		C47H77N13O15		CC(C)CC(C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CO)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CC(C)C)C(=O)O)N
TCMBANKIN015286	valine acid
TCMBANKIN017302	tryptophan acid
TCMBANKIN018715	histidine		C6H9CuN3O2	218.7 g/mol	C1=C(NC=N1)CC(C(=O)O)N.[Cu]
TCMBANKIN019832	Cysteine		C3H7NO2S	121.16 g/mol	C(C(C(=O)[O-])[NH3+])S
TCMBANKIN023626	phenylalanine	ZB003544; 2S-alpha-phenylalanine; L-phenylalanine zwitterion; (2S)-2-azaniumyl-3-phenylpropanoate; CHEBI:58095; CJ-00758; AC1OBQNX; Phenyl alanine; (2S)-2-ammonio-3-phenylpropanoate	C9H11NO2	165.19 g/mol	C1=CC=C(C=C1)CC(C(=O)[O-])[NH3+]
TCMBANKIN030424	methionine	4eg4; (2S)-2-azaniumyl-4-methylsulfanyl-butanoate; 4eg7; (2S)-2-ammonio-4-(methylsulfanyl)butanoate; 3f3d; (2S)-2-azaniumyl-4-(methylsulfanyl)butanoate; (2S)-2-ammonio-4-(methylthio)butanoate; CJ-24201; A834471; L-methionine zwitterion; 4ega; CHEBI:57844; 4eg6; 4eg5; CJ-05251; 3tun	C5H11NO2S	149.21 g/mol	CSCCC(C(=O)O)N
TCMBANKIN035904	calcium phosphate	Calipharm T; 915772-79-1; beta tricalcium phosphate; Calcium phosphates; alpha-Tricalcium phosphate; KSC377C4P; UNII-279O8I0433 component QORWJWZARLRLPR-UHFFFAOYSA-H; AC1Q22HV; 1269629-39-1; Synthos; Phosphoric acid calcium(2+) salt (2:3); Calcium phosphate, Reagent for transient & stable DNA transfections; 1344-15-6; EINECS 233-283-6; JAX TCP; Posture (TN); Multifos; Calcium phosphate tribasic; 12167-74-7 (tri-calcium salt); DB11348; AC1LANN3; Tricalcium phosphate hydrate; Ca3(PO4)2; tricalciumphosphate; MolPort-003-925-398; Tricalcium diphosphate; Tribasic calcium phosphate; UNII-K4C08XP666; Posture (calcium supplement); Calcium phosphate, purum p.a., >=96.0% (calc. as Ca3(PO4)2, KT); Cerasorb; 97Z1WI3NDX; bone phosphate; CCRIS 3668; Natural whitlockite; Caswell No. 148; beta-tri-Calcium phosphate, puriss. p.a., >=95% beta-phase basis (sintered powder); Bonarka; Synthograft; Ca3O8P2; 21063-37-6; FEMA No. 3081; AC1L2NG3; Ceredex; Tertiary calcium phosphate; calcium phosphate basic; 7758-87-4; EPA Pesticide Chemical Code 076401; 123211-19-8; C08136; alpha-TCP; CTK2H7147; AKOS015833108; Calcium orthophosphate; Calcium Phosphate Tribasic, Powder, Reagent; TR-024786; FT-0645103; Tricafos P; 1314234-39-3; 10103-46-5; alpha-tri-Calcium phosphate, Reagent for transient & stable DNA transfections; Phosphoric acid, calcium salt (2:3); Phosphoric acid, calcium salt; Calcium phosphate; Calcium phosphate tribasic 500g; Bone ash; K4C08XP666; BONE POWDER, PURIFIED; TricOs; tricalcium bis(phosphate); Calcium orthophosphate, tri-(tert); beta-tri-Calcium phosphate, puriss. p.a., >=98% beta-phase basis (sintered Powder); CS-0013475; AI3-25607; alpha-tri-Calcium phosphate, puriss. p.a., >=75% alpha-phase basis (sinterted powder); 7757-93-9 (CaHPO4); CHEBI:9679; Calcium phosphate, tribasic; Tricalcium orthophosphate; OSferion; Vitoss; TRICALCIUM PHOSPHATE; tert-Calcium phosphate; 21063-37-6 (monetite); LS-2435; RTR-024786; tri-Calcium (ortho)phosphate; Calcigenol simple; tri-calcium phosphate; Tricalcium bis(orthophosphate); CHEMBL2106566; 1160697-13-1; Calcium phosphate (3:2); DTXSID1049803; Tricalcium phosphate hydrate, nanopowder, <200 nm particle size (BET); EC 231-840-8; D00938; Tricalcium bis(orthophosphate), with a fluorine content of less than 0,005 % by weight on the dry anhydrous product; beta-tri-Calcium phosphate, puriss. p.a., >=98% beta-phase basis (unsintered powder); Tricalcium phosphate (Ca3(PO4)2); Calcium tertiary phosphate; UNII-97Z1WI3NDX; Hydroxyapatite Powder; S338; Calcium phosphate (Ca3(PO4)2); beta-Tricalcium phosphate; KS-000011AF; beta-TCP; Ostram; beta-tri-Calcium phosphate, >=95% beta-phase basis (unsintered powder); calcium-phosphate; HSDB 879; QORWJWZARLRLPR-UHFFFAOYSA-H; EINECS 231-840-8; Phosphoric acid, calcium salt (1:?)	Ca5(PO4)3?OH or Ca3(PO4)2	310.2 g/mol	[O-]P(=O)([O-])[O-].[O-]P(=O)([O-])[O-].[Ca+2].[Ca+2].[Ca+2]
TCMBANKIN039597	glutamic acid	AC1NP0EB; L-glutamate; [(2S)-1,5-dihydroxy-1,5-dioxopentan-2-yl]azanium; (2S)-2-Ammonioglutaric acid; 4o3b; 3dln; 3u93; 1s50; 2c6g; 3lmk; 4io2; 2i3v; 2a5s	C5H10NO4+	148.14 g/mol	C(CC(=O)O)C(C(=O)O)[NH3+]
TCMBANKIN044059	threonine	1219-EP2301538A1; 1219-EP2301533A1; 1219-EP2301536A1; 1219-EP2316831A1; 1219-EP2292614A1; 1219-EP2277898A2; 1219-EP2298743A1; 1219-EP2311453A1; 1219-EP2301933A1; 1219-EP2270008A1; 1219-EP2295055A2; 1219-EP2284157A1; 1219-EP2280003A2; 1219-EP2311494A1; 1219-EP2287165A2; 1219-EP2295412A1; 1219-EP2281815A1; 1219-EP2305250A1; 1219-EP2305640A2; 1219-EP2316452A1; 1219-EP2314574A1; 1219-EP2284179A2; 174753-EP2285797A1; 1219-EP2301923A1; 1219-EP2301940A1; 1219-EP2308877A1; 1219-EP2292088A1; 1219-EP2292589A1; 1219-EP2305671A1; 1219-EP2279741A2; 1219-EP2277867A2; 1219-EP2292617A1; 1219-EP2295410A1; 1219-EP2292620A2; 1219-EP2311842A2; 1219-EP2311840A1; 1219-EP2316835A1; 1219-EP2277876A1; 1219-EP2295432A1; 1219-EP2298780A1; 1219-EP2289892A1; 1219-EP2305808A1; 1219-EP2316470A2; 1219-EP2298748A2; 1219-EP2295402A2; 1219-EP2295550A2; 1219-EP2308879A1; 1219-EP2280012A2; 1219-EP2305689A1; 1219-EP2295427A1; 1219-EP2311827A1; 1219-EP2292615A1; 1219-EP2285797A1; 1219-EP2289894A2; 1219-EP2270001A1; 1219-EP2311837A1; 1219-EP2316834A1; 1219-EP2280011A1; 1219-EP2277877A1; 1219-EP2275102A1; 1219-EP2289893A1; 1219-EP2295413A1; 1219-EP2301928A1; 1219-EP2269988A2; 1219-EP2284178A2; 1219-EP2269993A1; 1219-EP2287166A2; 1219-EP2295416A2; 1219-EP2301939A1; 1219-EP2295426A1; 1219-EP2311455A1; 1219-EP2305682A1; 1219-EP2270018A1; 1219-EP2277881A1; 1219-EP2272517A1	C4H9NO3	119.12 g/mol	CC(C(C(=O)O)N)O
TCMBANKIN057923	glycin	Tocris-0219; G5417_SIGMA; WLN: Z1VQ; LS-218; 56-40-6; Glycosthene; G7126_SIGMA; Hgly; Glycine-UL-14C hydrochloride; EINECS 200-272-2; Padil; Polyglycine II; AB-131/40217813; Acido aminoacetico [INN-Spanish]; Glycine [INN]; G7403_SIGMA; CCRIS 5915; GLY (IUPAC abbrev); W328707_ALDRICH; Glycine-2-3H; G3649_SIGMA; InChI=1/C2H5NO2/c3-1-2(4)5/h1,3H2,(H,4,5; Glycine iron sulphate (1:1); NSC 25936; P8791_SIGMA; Leimzucker; Gyn-Hydralin; D00011; Aminoessigsaeure; 50046_FLUKA; Acidum aminoaceticum [INN-Latin]; Aminoethanoic acid; aminoacetic acid; AI3-04085; 33242-26-1; H2N-CH2-COOH; C00037; G8898_SIGMA; Glyzin; G0398_SIGMA; Amitone; Hampshire glycine; Glycocoll; G5523_SIGMA; Acide aminoacetique [INN-French]; Glycine-carboxy-14C hydrochloride; Glicina [INN-Spanish]; Glycinum [INN-Latin]; Glykokoll; ST5213923; 15527_RIEDEL; 7490-95-1; NChemBio.2007.13-comp1; Glycine, non-medical; BPBio1_001222; Biomol-NT_000195; 57678-19-0; Glycolixir; 63183-41-5; 87867-94-5; HSDB 495; AIDS071643; FEMA No. 3287; CHEBI:15428; 33226_RIEDEL; Sucre de gelatine; 17829-66-2; 410225_SIAL; NCGC00024503-01; 2-Aminoacetic acid; Aminoazijnzuur; NSC25936; Glycine (JP15/USP); polyglycine; 52955-63-2; carbonocyanidic acid; 32817-15-5; 2-aminoethanoic acid; Aciport; L-Glycine; Glicoamin; 25718-94-9; Acetic acid, amino-; G8790_SIGMA; AIDS-071643; NCGC00024503-02; Glycine, homopolymer (VAN); glycine;CHEMBL451140; N'-[N-(2a,3b-Dihydroxy-12-oleanen-28-oyl)-L-alanyl]-glycine; 2-[[(2S)-2-[[(4aS,6aR,6aS,6bR,8aR,10R,11R,12aR,14bS)-10,11-dihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carbonyl]amino]propanoyl]amino]acetic acid;GLY	C2H5NO2	75.07 g/mol	C(C(=O)O)N
TCMBANKIN057927	D-Asparaginsaeure	(R)-Aspartic acid; Tocris-0213; Lopac-A-9256; (2R)-2-aminosuccinic acid; NCGC00024498-01; aspartic acid D-form; Biomol-NT_000167; (2R)-2-aminobutanedioic acid; (R)-2-aminobutanedioic acid; C00402; NCGC00015104-01; PDSP1_001545; NCGC00024498-03; (-)-Aspartic acid; (R)-2-aminosuccinic acid; Aspartic acid, D-; InChI=1/C4H7NO4/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H,6,7)(H,8,9; BPBio1_001126; PDSP2_001529; 219096_ALDRICH; NCGC00024498-02; BRN 1723529; CHEBI:17364; NSC 97922; EINECS 217-234-6; (R)-(−)-Aminosuccinic acid;AC1O70SP; (3S)-3-amino-4-oxobutanoic acid; (S)-3-Formyl-beta-alanine; AKOS006351600; SCHEMBL8536	C13H15NO6	281.26	C(C(C(=O)O)N)C(=O)O
TCMBANKIN057929	serine	(s)-serine;H-Ser; Serinum [Latin]; 56-45-1; SCHEMBL1775; L-Serine, Vetec(TM) reagent grade, >=99%; bmse000867; (2S)-2-amino-3-hydroxypropanoic acid; Serine (L-Serine); EC 200-274-3; 6898-95-9; CS-W020136; L-Serine, homopolymer; CHEBI:17115; H-Ser-OH; S0035; L-Serine, PharmaGrade, Ajinomoto, EP, USP, manufactured under appropriate GMP controls for Pharma or Biopharmaceutical production, suitable for cell culture; 2-Amino-3-hydroxypropanoic acid-, (S)-; b-Hydroxy-L-alanine; Propanoic acid, 2-amino-3-hydroxy-, (S); L-2-Amino-3-hydroxypropanoic Acid; BRN 1721404; EBD2198140; BC676679; Serinum; Serine (VAN); L-Serine;; NSC760115; (S)-(-)-Serine; AJ-24136; L-3-Hydroxy-2-aminopropionic acid; UNII-00PAR1C66F component MTCFGRXMJLQNBG-REOHCLBHSA-N; EINECS 200-274-3; TC-066532; L-Serine, from non-animal source, meets EP, USP testing specifications, suitable for cell culture, 98.5-101.0%; ZINC895034; TL806218; (L)-SERINE; 61748-67-2; L-Serine, Vetec(TM), 98.5%; L-Serine, PharmaGrade, Ajinomoto, EP, USP, JP, Manufactured under appropriate controls for use in pharma or biopharmaceutical production, suitable for cell culture; NCGC00015952-01; Serine (USP); beta-Hydroxyalanine; L-Serine, BioUltra, >=99.5% (NT); Racemic serine; L-Serin; (S)-beta-Amino-3-hydroxypropionate; L-(-)-Serine; NSC 118365; Pharmakon1600-01301010; BR-73019; AK-73019; AmbotzHAA1129; (-)-Serine; (S)-alpha-Amino-beta-hydroxypropionic acid; (2S)-2-amino-3-hydroxy-propanoic acid; CTK1G9788; GTPL726; 452VLY9402; DB00133; 88848-EP2289892A1; MFCD00064224; l-2-Amino-3-hydroxy-propanoic acid; (S)-(+)-2-Amino-3-hydroxypropionic acid; Tocris-0226; (2S)-2-AMINO-2-CARBOXY-1-HYDROXYETHYL; AKOS015854115; 154605-73-9; bmse000048; alpha-Amino-beta-hydroxypropionic acid; bmse000809; MolPort-003-939-270; ser; LS-144975; 88848-EP2305825A1; (S)-a-Amino-b-hydroxypropionic acid; serine; RP09655; DB-029983; RP18847; AC1L1LHF; L-Serine (JP17); L-Serine, Pharmaceutical Secondary Standard; Certified Reference Material; AC-1190; .beta.-Hydroxyalanine; KSC269O8R; KB-53386; BDBM50357212; RTC-066532; NCGC00024507-02; NSC-760115; Lopac-S-4250; D00016; Serina; Propanoic acid, 2-amino-3-hydroxy-, (S)-; NCGC00024507-01; (S)-2-Amino-3-hydroxypropanoic acid; Polyserine; L-Serine, United States Pharmacopeia (USP) Reference Standard; MCULE-5604658333; AM20100375; (S)-Serine; SC-09827; Tocris-0227; L-2-Amino-3-hydroxypropionic acid; bmse000885; AB1002443; UNII-452VLY9402; beta-Hydroxy-L-alanine; 064S224; Serina [Spanish]; L-Serine, Cell Culture Reagent; HSDB 680; Serine, L-; FT-0693445; Serine, European Pharmacopoeia (EP) Reference Standard; L-serine; 3h-l-serine; C00065; (S)-alpha-Amino-beta-hydroxypropionate; L-Serine, certified reference material, TraceCERT(R); Serine [USAN:INN]; 25821-52-7; .alpha.-Amino-.beta.-hydroxypropionic acid-, (S)-; 2-Amino-3-hydroxypropanoic acid, (S)-; F1905-7047; (S)-2-amino-3-hydroxy-Propanoate; (S)-beta-Amino-3-hydroxypropionic acid; L-Serine, ReagentPlus(R), >=99% (HPLC); (S)-2-Amino-3-hydroxypropionic acid; L-Serine, >=99.0% (NT); SR-01000597708; (S)-2-Amino-3-hydroxypropanoate; AN-24441; ST2408299; BP-13282; (S)-2-amino-3-hydroxy-Propanoic acid; CHEMBL11298; 3-hydroxy-L-Alanine; MTCFGRXMJLQNBG-REOHCLBHSA-N; L-Serine, tested according to Ph.Eur.; D0T6GM; PubChem10994; VC30786; Epitope ID:150900; L-3-Hydroxy-2-aminopropionate; L-3-Hydroxy-alanine; M-6047; FT-0627627; Z1270387256; SR-01000597708-1; 3AB40D3A-043A-488F-8361-D1BF309F842C; 4-04-00-03118 (Beilstein Handbook Reference); AB0008559; (S)-a-Amino-b-hydroxypropionate; SER (IUPAC abbrev); L-Alanine, 3-hydroxy-; L-ser; ACT08366; (S)-b-Amino-3-hydroxypropionate; (S)-b-Amino-3-hydroxypropionic acid; 2-Amino-3-hydroxypropionic acid; Poly-L-serine; ANW-32514; rac-serine;(S)-2-Amino-3-hydroxypropionic acid; 2-Amino-3-hydroxypropanoic acid; Serinum [Latin]; S4311_SIGMA; NCGC00024507-02; NSC 118365; Lopac-S-4250; D00016; (2S)-2-amino-3-hydroxypropanoic acid; (-)-Serine; (2S)-2-amino-3-hydroxy-propionic acid; Propanoic acid, 2-amino-3-hydroxy-, (S)-; (S)-alpha-Amino-beta-hydroxypropionic acid; 6898-95-9; (2S)-2-amino-3-hydroxy-propanoic acid; NCGC00024507-01; L-Serine, homopolymer; CHEBI:17115; (S)-2-Amino-3-hydroxypropanoic acid; Polyserine; Propanoic acid, 2-amino-3-hydroxy-, (S); L-3-Hydroxy-alanine; Tocris-0226; (S)-Serine; Tocris-0227; BRN 1721404; L-2-Amino-3-hydroxypropionic acid; beta-Hydroxy-L-alanine; Serina [Spanish]; Serine (VAN); 84959_FLUKA; alpha-Amino-beta-hydroxypropionic acid; HSDB 680; Serine, L-; C00065; 4-04-00-03118 (Beilstein Handbook Reference); L-3-Hydroxy-2-aminopropionic acid; EINECS 200-274-3; L-Serine (JAN); SER (IUPAC abbrev); Serine [USAN:INN]; 25821-52-7; 78682_FLUKA; 2-Amino-3-hydroxypropanoic acid, (S)-; L-Alanine, 3-hydroxy-; S1315_SIGMA; NCGC00015952-01; Serine (USP); Poly-L-serine; beta-Hydroxyalanine; S4500_SIGMA;L-Serin	C3H7NO3	105.09 g/mol	C(C(C(=O)O)N)O
TCMBANKIN057965	arginine	L(+ )-arginine;EINECS 230-571-3; (2S)-2-amino-5-guanidino-pentanoic acid; EINECS 200-811-1; (S)-2-Amino-5-guanidinovaleric acid; DL-Arginine; (L)-Arginine; Arginine hydrochloride(USAN); 1-Amino-4-guanidovaleric acid; L-Ornithine, N5-(aminoiminomethyl)-; W381918_ALDRICH; (2S)-2-amino-5-(diaminomethylideneamino)pentanoic acid; Arginine [USAN:INN]; S-(+)-2-Amino-5-[(aminoiminomethyl)amino]pentanoic acid; L-Arginine, labeled with tritium; AI3-24165; AIDS-121865; (S)-2-Amino-5-[(aminoiminomethyl)amino]pentanoic acid; NSC203450 (HYDROCHLORIDE); A5006_SIAL; (+-)-Arginine; L-Norvaline, 5-((aminoiminomethyl)amino)-; AIDS121865; Lopac0_000077; Tocris-0663; Arginine (VAN); 4455-52-1; CCRIS 3609; BRN 1725413; NCGC00015064-01; (2S)-2-amino-5-(carbamimidamido)pentanoic acid; (2S)-2-amino-5-guanidinopentanoic acid; D02982; Argininum [INN-Latin]; C00062; 7200-25-1; A8094_SIGMA; 11009_FLUKA; Poly(L-arginine); (2S)-2-amino-5-guanidino-valeric acid; Lopac-A-5006; NSC 206269; HSDB 1429; CHEBI:16467; L-Arginine, homopolymer; L-Arginine (9CI); Arginina [INN-Spanish]; 4-04-00-02648 (Beilstein Handbook Reference); (S)-2-amino-5-guanidinopentanoic acid; (S)-2-Amino-5-((aminoiminomethyl)amino)pentanoic acid; Arginine, L- (8CI); L-Arginine (JP15); EU-0100077; L-alpha-Amino-delta-guanidinovaleric acid; NSC7914 (HYDROCHLORIDE); Arginine (USP); 1119-34-2 (HYDROCHLORIDE); Pentanoic acid, 2-amino-5-((aminoiminomethyl)amino)-, (S)-; L-Arg; L-Norvaline, 5-[(aminoiminomethyl)amino]-; 142-49-4; A4474_SIAL; InChI=1/C6H14N4O2/c7-4(5(11)12)2-1-3-10-6(8)9/h4H,1-3,7H2,(H,11,12)(H4,8,9,10)/t4-/m0/s; L-Arginin; Arginine, DL-; NCGC00024715-01;AC1ODX8E; [(4S)-5-amino-4-azaniumyl-5-oxopentyl]-(diaminomethylidene)azanium; [AMINO({[(4S)-4-AMMONIO-4-CARBAMOYLBUTYL]AMINO})METHYLIDENE]AZANIUM	C6H14N4O2	174.2 g/mol	C(CC(C(=O)O)N)CN=C(N)N
TCMBANKIN058586	Prolinum	(-)-Proline (S)-2-Carboxypyrrolidine; 18875-45-1; (2S)-2-pyrrolidinecarboxylic acid; P5607_SIGMA; L-Proline-15N; AIDS018625; 4305-67-3; L-Proline, labeled with carbon-14; L-Proline (JAN); L-(-)-Proline; CHEBI:17203; 37159-97-0; Carboxypyrrolidine; P0380_SIAL; (-)-(S)-Proline; Proline (USP); D00035; NCGC00014017; W331902_ALDRICH; (2S)-pyrrolidine-2-carboxylic acid; (S)-pyrrolidine-2-carboxylic acid; L-Prolin; NSC-97923; P8865_SIAL; nchembio816-comp9; AIDS-018625; L-(2,3-3H)Proline; C00148; 4607-28-7; 81710_FLUKA; (2S)-proline; 608998_ALDRICH; 81709_FLUKA; proline	C5H9NO2	115.13 g/mol	C1CC(NC1)C(=O)O
TCMBANKIN059065	alanine	3ip5; D09ADQ; [14C]-alanine; D0X1RG; CJ-12185; L-alanine zwitterion; CHEBI:57972; 3f48; [14C]alanine; (2S)-2-azaniumylpropanoate; [3H]alanine; (2S)-2-ammoniopropanoate; AC1OIZQD; [3H]-alanine;DAL	C3H7NO2	89.09 g/mol	CC(C(=O)O)N
TCMBANKIN059238	l-leucine	(2S)-2-ammonio-4-methylpentanoate; AC1OF6E5; L-Leu; (2S)-2-azaniumyl-4-methylpentanoate; L-leucine zwitterion; 3b3s; 3b3w; (2S)-2-azaniumyl-4-methyl-pentanoate; A833479; CHEBI:57427; 3gjd; 3f3e; 4fxz; leucine zwitterion; CJ-10705; leucine	C6H13NO2	131.17 g/mol	CC(C)CC(C(=O)[O-])[NH3+]

植物对应的疾病

疾病ID	病名	疾病类型	MeSH	参考文献

植物对应的靶点

靶点ID	基因名	基因别名	描述	染色体位置	Map_Location	基因类型